logo

Stock Screener

Forex Screener

Crypto Screener

CAH

Cardinal Health, Inc. (CAH)

$

214.88

+3.65 (1.70%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

18.7059

Market cap

Market cap

51.1 Billion

Price to sales ratio

Price to sales ratio

0.2179

Debt to equity

Debt to equity

-3.1372

Current ratio

Current ratio

0.9570

Income quality

Income quality

3.1239

Average inventory

Average inventory

17.2 Billion

ROE

ROE

-0.5500



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Cardinal Health, Inc. operates as an integrated healthcare services and products company providing customized solutions across the United States, Canada, Europe, Asia, and other international markets. The company offers tailored services to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home care patients. The company functions in two primary segments: Pharmaceutical and Medical. The Pharmaceutical segment is responsible for distributing both branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare products. Additionally, it supports pharmaceutical manufacturers and healthcare providers through various services linked to specialty pharmaceuticals; manages nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic and over-the-counter healthcare products; and delivers medication therapy management and patient outcomes services to hospitals, healthcare providers, and payers. The operational income ratio is 0.01 indicating the company's operational profitability margin, while the company recorded an operating income of $2,275,000,000.00 reflecting its earnings from core operations. The income before tax ratio stands at 0.01 which shows the pre-tax margin. On the stock market, the company’s stock is identified with the symbol 'CAH', and the gross profit is $8,168,000,000.00 highlighting the company's profitability from its core operations. Conversely, the Medical segment involves the manufacture, sourcing, and distribution of Cardinal Health branded medical, surgical, and laboratory products, along with a comprehensive range of solutions for healthcare providers. The stock is reasonably priced at $149.60 appealing to a broad array of investors. With a high average trading volume of 2,122,326.00 it demonstrates strong liquidity in the market. The company boasts a mid-range market capitalization of $51,054,422,625.00 positioning it as a steady performer within the industry. As a key player in the Medical - Distribution industry, Cardinal Health significantly contributes to the overall market landscape and embraces its role in driving innovation and growth as part of the Healthcare sector. The combination of a robust product portfolio, strategic market presence, and solid financial metrics underlines the company's commitment to delivering effective healthcare solutions.

What is Cardinal Health, Inc. (CAH)'s current stock price?

The current stock price of Cardinal Health, Inc. (CAH) is $214.88 as of 2026-01-30. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Cardinal Health, Inc. (CAH) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict Cardinal Health, Inc. stock to fluctuate between $120.72 (low) and $216.51 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2026-01-30, Cardinal Health, Inc.'s market cap is $51,054,422,625, based on 237,595,042 outstanding shares.

Compared to Eli Lilly & Co., Cardinal Health, Inc. has a Lower Market-Cap, indicating a difference in performance.

Cardinal Health, Inc. pays dividends. The current dividend yield is 0.99%, with a payout of $0.51 per share.

To buy Cardinal Health, Inc. (CAH) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CAH. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

Cardinal Health, Inc.'s last stock split was 3:2 on 2001-04-23.

Revenue: $222,578,000,000 | EPS: $6.48 | Growth: 86.21%.

Visit https://www.cardinalhealth.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $216.51 (2026-01-29) | All-time low: $45.85 (2021-12-01).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

CAH

zacks.com

Is Cardinal Health (CAH) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CAH

zacks.com

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CAH

zacks.com

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) reached $210.93 at the closing of the latest trading day, reflecting a +1.25% change compared to its last close.

CAH

zacks.com

Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

CAH

seekingalpha.com

Cardinal Health Upgraded As It Maintains Investment-Grade Status And Position In Radiopharmaceuticals

Cardinal Health gets upgraded to a buy, despite its price having gone up over 100% since my bullish call in early 2024. CAH could benefit from longer-term macro demand for medical supplies, mitigating near-term provider margin pressures. Recent growth drivers include positive FY26 guidance, the Solaris Health acquisition, innovative product launches, and advances in nuclear medicine mentioned in the article.

CAH

zacks.com

3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)

Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

CAH

zacks.com

Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CAH

zacks.com

Why the Market Dipped But Cardinal Health (CAH) Gained Today

In the latest trading session, Cardinal Health (CAH) closed at $208.26, marking a +2.83% move from the previous day.

CAH

seekingalpha.com

Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CAH

barrons.com

Cardinal Health Stock Jumps on Guidance Raise. Why 2026 Will Be a Good Year.

The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener